BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • BNT162 Vaccine*
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Immunity
  • Lung
  • RNA, Messenger
  • SARS-CoV-2
  • Young Adult

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine